Accueil du site > Revue de presse > Sources d’information > Médical > AIDS Treatment News Daily Alerts
AIDS Treatment News Daily Alerts
-
Kennedy Announces Plan to Submit Bill For Universal Care
"Kennedy has a head start on them all. Despite his illness, he directed his staff months ago to begin work on legislation that would vastly expand health coverage, a career-long goal of his. " Read more in Washington Post, November 18, (...)
-
Rallies Protest HIV-Related Travel Restrictions Worldwide
"Ctrl.Alt.Shift project manager Neil Boorman told CNN that the bans and restrictions further the spread of the epidemic by driving the issue underground and forcing people to lie about their health on visa applications." Read more in POZ, November 17, (...)
-
HIV Co-Discoverer Calls for Domestic PEPFAR Plan
"In an opinion piece published in the November 16 edition of The Washington Post, Robert C. Gallo, MD—director of the Institute of Human Virology in Baltimore and co-discoverer of the HIV retrovirus—praised George W. Bush’s President’s Emergency Plan for AIDS Relief (PEPFAR) for providing treatment (...)
-
Atripla Users May Be Able to Take Weekend Treatment Breaks
"In an effort to alleviate the inconvenience and other drawbacks of life-long daily treatment, many patients with HIV wish to take "drug holidays," or periodic breaks from antiretroviral therapy. "Several studies -- including the large SMART treatment interruption trial -- have shown that (...)
-
Ginkgo Biloba Ineffective Against Dementia, Researchers Find
"The largest and longest independent clinical trial to assess ginkgo biloba’s ability to prevent memory loss has found that the supplement does not prevent or delay dementia or Alzheimer’s disease, researchers are reporting. "The study is the first trial large enough to accurately assess the (...)
-
Yes, Just a Case Report, but Incredibly Cool
"Now the story has been updated in the Wall Street Journal – the patient is now off antivirals for over 600 days, still no virus rebound. Today it’s the most e-mailed piece in the Journal. "Just a hunch, but I think this is the closest thing we’ve come to a cure for HIV infection." Read more in (...)
-
Major AIDS march this week, November 20, Washington D.C.
"Specific Policy Demands for Nov. 20th Protest "The next president’s transition team must meet with people living with HIV and community activists to hear firsthand the devastation of the HIV epidemic at home and abroad, and hear solutions to effectively fight HIV/AIDS. "The next President, (...)
-
Second-line combinations fail twice as often as first-line ones in the first year
"Although the success rates are still encouraging, a study from London’s Royal Free Hospital has found that roughly twice as many second-line anti-HIV drug regimens stop working in the first year as first-line regimens, and that this difference in failure rates persists until at least the third (...)
-
IL-2 provides quick ‘AIDS rescue’, but effect does not always last
"IL-2 is a naturally-occurring cytokine (immune-modulating protein) that can also be made artificially. It produces significant rises in CD4 counts in the majority of people who take it by lengthening the lives of CD4 cells. It has been the subject of two long-running drug trials in people with (...)
-
ACP Offers Guidelines on Second-Generation Antidepressants
"The guidelines, which appear in Annals of Internal Medicine, derive from an analysis of nearly 30 years' worth of published research on 12 drugs: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and (...)